A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Angela Dispenzieri, Gregory A. Wiseman, Martha Q. Lacy, Suzanne R. Hayman, Shaji K. Kumar, Francis Buadi, David Dingli, Krista M. Laumann, Jake Allred, Susan M. Geyer, Mark R. Litzow, Dennis A. Gastineau, David J. Inwards, Ivana N. Micallef, Stephen M. Ansell, Luis Porrata, Michelle A. Elliott, Patrick B. Johnston, William J. Hogan, Morie A. Gertz

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences